Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Substrate-specific forms of human platelet phospholipase A2.

L R Ballou, L M DeWitt, W Y Cheung

The Journal of Biological Chemistry

|March 5, 1986

Summary

Human platelets contain at least two forms of phospholipase A2 (PLA2). These enzymes show substrate specificity for phosphatidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn), with distinct properties influencing their activity and stability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial.

Nature medicine·2024

Same author

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Immunotherapy advances·2022

Same author

Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021

Same author

Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil.

Current oncology (Toronto, Ont.)·2020

Same author

A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes.

Current oncology (Toronto, Ont.)·2020

Same author

Subtype-specific risk factors for postmenopausal breast cancer: findings from the PLCO trial.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020

Area of Science:

Biochemistry
Enzymology
Platelet Biology

Background:

Phospholipase A2 (PLA2) enzymes are crucial in releasing fatty acids from phospholipids.
Human platelets are a rich source of enzymes involved in lipid metabolism and signaling.

Purpose of the Study:

To investigate the substrate specificity and properties of human platelet phospholipase A2.
To determine if distinct PLA2 forms exist in human platelets based on their preferred phospholipid substrates.

Main Methods:

Ion-exchange chromatography was used to purify and resolve PLA2 activity from human platelet particulate fractions.
Enzyme activity was assayed using phosphatidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn) as substrates.
Chromatographic conditions, including temperature and detergent treatment, were varied to assess enzyme behavior.

Main Results:

A single PLA2 activity peak was observed at 4°C, catalyzing hydrolysis of both PtdCho and PtdEtn.
Distinct optimal conditions, Ca2+ requirements, and substrate affinities were found for PtdCho and PtdEtn hydrolysis.
Running chromatography at 22°C or using mild sonication with octylglucoside resolved distinct PLA2 peaks specific for PtdEtn or PtdCho, respectively.
Isolated specific PLA2 forms were labile, unlike the more stable aggregated form.

Conclusions:

Human platelets possess at least two distinct, substrate-specific forms of phospholipase A2.
One form preferentially acts on PtdCho, while another acts on PtdEtn.
These findings highlight the complexity of arachidonic acid release pathways in platelets.

Related Experiment Videos